Multiparameter Monitoring with a Wearable Cardioverter Defibrillator

Rohrer, Ursula; Manninger, Martin; Zirlik, Andreas; Scherr, Daniel

doi:10.3390/s22010022

Cited by 5 publications

(4 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Telemedical and non-invasive techniques are highly sought after for monitoring patients and as presented in the introduction, in cases such as melanoma, they are gaining support to replace medical examinations [5]. They are also widely used in monitoring other medical issues and vital signs including heart failure [35], respiratory [36], heart rate variability [37], fall detection [38] and anxiety [39]. These examples do not require complex laboratory equipment or a controlled environment and in most cases can be performed in the comfort of the patient's home [40].…”

Section: Telemedical and Non-invasive Measurementsmentioning

confidence: 99%

Electromagnetic Sensing Techniques for Monitoring Atopic Dermatitis—Current Practices and Possible Advancements: A Review

Todorov

Torah

Ardern‐Jones

et al. 2023

Sensors

View full text Add to dashboard Cite

Atopic dermatitis (AD) is one of the most common skin disorders, affecting nearly one-fifth of children and adolescents worldwide, and currently, the only method of monitoring the condition is through an in-person visual examination by a clinician. This method of assessment poses an inherent risk of subjectivity and can be restrictive to patients who do not have access to or cannot visit hospitals. Advances in digital sensing technologies can serve as a foundation for the development of a new generation of e-health devices that provide accurate and empirical evaluation of the condition to patients worldwide. The goal of this review is to study the past, present, and future of AD monitoring. First, current medical practices such as biopsy, tape stripping and blood serum are discussed with their merits and demerits. Then, alternative digital methods of medical evaluation are highlighted with the focus on non-invasive monitoring using biomarkers of AD—TEWL, skin permittivity, elasticity, and pruritus. Finally, possible future technologies are showcased such as radio frequency reflectometry and optical spectroscopy along with a short discussion to provoke research into improving the current techniques and employing the new ones to develop an AD monitoring device, which could eventually facilitate medical diagnosis.

show abstract

Section: Telemedical and Non-invasive Measurementsmentioning

confidence: 99%

Electromagnetic Sensing Techniques for Monitoring Atopic Dermatitis—Current Practices and Possible Advancements: A Review

Todorov

Torah

Ardern‐Jones

et al. 2023

Sensors

View full text Add to dashboard Cite

show abstract

“…In instances where there is a transient risk for SCD, individuals may be considered suitable candidates for a wearable cardioverter defibrillator (WCD). The WCD also serves as a viable alternative for individuals awaiting ICD implantation or those following ICD explanation, such as cases related to infections or endocarditis [89].…”

Section: Discussionmentioning

confidence: 99%

Harmony in Chaos: Deciphering the Influence of Ischemic Cardiomyopathy and Non-Cardiac Comorbidities on Holter ECG Parameters in Chronic Heart Failure Patients: A Pilot Study

Duca,

Badescu,

Costache

et al. 2024

Medicina

View full text Add to dashboard Cite

Background and Objective: In the landscape of heart failure, non-cardiac comorbidities represent a formidable challenge, imparting adverse prognostic implications. Holter ECG monitoring assumes a supplementary role in delineating myocardial susceptibility and autonomic nervous system dynamics. This study aims to explore the potential correlation between Holter ECG parameters and comorbidities in individuals with ischemic cardiomyopathy experiencing heart failure (HF), with a particular focus on the primary utility of these parameters as prognostic indicators. Materials and Methods: In this prospective inquiry, a cohort of 60 individuals diagnosed with heart failure underwent stratification into subgroups based on the presence of comorbidities, including diabetes, chronic kidney disease, obesity, or hyperuricemia. Upon admission, a thorough evaluation of all participants encompassed echocardiography, laboratory panel analysis, and 24 h Holter monitoring. Results: Significant associations were uncovered between diabetes and unconventional physiological indicators, specifically the Triangular index (p = 0.035) and deceleration capacity (p = 0.002). Pertaining to creatinine clearance, notable correlations surfaced with RMSSD (p = 0.026), PNN50 (p = 0.013), and high-frequency power (p = 0.026). An examination of uric acid levels and distinctive Holter ECG patterns unveiled statistical significance, particularly regarding the deceleration capacity (p = 0.045). Nevertheless, in the evaluation of the Body Mass Index, no statistically significant findings emerged concerning Holter ECG parameters. Conclusions: The identified statistical correlations between non-cardiac comorbidities and patterns elucidated in Holter ECG recordings underscore the heightened diagnostic utility of this investigative modality in the comprehensive evaluation of individuals grappling with HF. Furthermore, we underscore the critical importance of the thorough analysis of Holter ECG recordings, particularly with regard to subtle and emerging parameters that may be overlooked or insufficiently acknowledged.

show abstract

“…All these features and the amount of remotely transmitted data allow a rigorous management of the patient, giving the physician the possibility to identify the need for a therapeutic adaptation thus potentially avoiding unplanned access to the Hospital for acute decompensation events. 81 Potential functions that could be added in the future are the calculation of heart rate variability and the measurement of pulmonary congestion, the latter already included in another device of the same manufacturer.…”

Section: Future Potentialmentioning

confidence: 99%

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death

Casolo

Gulizia

Aschieri

et al. 2023

European Heart Journal Supplements

View full text Add to dashboard Cite

Extended risk stratification and optimal management of patients with a permanently increased risk of sudden cardiac death (SCD) are becoming increasingly important. There are several clinical conditions where the risk of arrhythmic death is present albeit only transient. As an example, patients with depressed left ventricular function have a high risk of SCD that may be only transient if there will be a significant recovery of function. It is important to protect the patients while receiving and titrating to the optimal dose the recommended drugs that may lead to an improved left ventricular function. In several other conditions, a transient risk of SCD can be observed even if the left ventricular function is not compromised. Examples are patients with acute myocarditis, during the diagnostic work-up of some arrhythmic conditions or after extraction of infected catheters while eradicating the associated infection. In all these conditions, it is important to offer a protection to these patients. The wearable cardioverter defibrillator (WCD) is of particular importance as a temporary non-invasive technology for both arrhythmia monitoring and therapy in patients with increased risk of SCD. Previous studies have shown the WCD to be an effective and safe therapy for the prevention of SCD caused by ventricular tachycardia/fibrillation. The aim of this ANMCO position paper is to provide a recommendation for clinical utilization of the WCD in Italy, based upon current data and international guidelines. In this document, we will review the WCD functionality, indications, clinical evidence, and guideline recommendations. Finally, a recommendation for the utilization of the WCD in routine clinical practice will be presented, in order to provide physicians with a practical guidance for SCD risk stratification in patients who may benefit from this device.

show abstract

Multiparameter Monitoring with a Wearable Cardioverter Defibrillator

Cited by 5 publications

References 62 publications

Electromagnetic Sensing Techniques for Monitoring Atopic Dermatitis—Current Practices and Possible Advancements: A Review

Electromagnetic Sensing Techniques for Monitoring Atopic Dermatitis—Current Practices and Possible Advancements: A Review

Harmony in Chaos: Deciphering the Influence of Ischemic Cardiomyopathy and Non-Cardiac Comorbidities on Holter ECG Parameters in Chronic Heart Failure Patients: A Pilot Study

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death

Contact Info

Product

Resources

About